Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down0.37% Nasdaq Down0.28%

Repros Therapeutics Inc. (RPRX)

-NasdaqCM

15.90 Up 0.40(2.58%) 10:28AM EDT - Nasdaq Real Time Price

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Sep 29, 2012Jun 29, 2012Mar 30, 2012
Total Revenue -   -   1   -  
Cost of Revenue -   -   -   -  
Gross Profit -   -   1   -  
Operating Expenses
Research Development6,308  3,132  2,178  1,466  
Selling General and Administrative1,067  1,452  923  973  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (7,375) (4,584) (3,100) (2,439)
Income from Continuing Operations
Total Other Income/Expenses Net1   -   -   -  
Earnings Before Interest And Taxes(7,374)(4,584)(3,100)(2,439)
Interest Expense -   -   -   -  
Income Before Tax(7,374)(4,584)(3,100)(2,439)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(7,374)(4,584)(3,100)(2,439)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (7,374) (4,584) (3,100) (2,439)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (7,374) (4,584) (3,100) (2,439)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.